XTANT MEDICAL HOLDINGS, INC. Proceeds from Debt, Net of Issuance Costs
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Proceeds from Debt, Net of Issuance Costs of $12.79 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2018-04-05
- XTANT MEDICAL HOLDINGS, INC. proceeds from debt, net of issuance costs for fiscal 2017 was $12.79M, a 294.89% increase from fiscal 2016.
- XTANT MEDICAL HOLDINGS, INC. proceeds from debt, net of issuance costs for fiscal 2016 was $3.24M.
| Period end | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|
| 2017-12-31 | $12.79M 10-K · filed 2018-04-05 |
| 2016-12-31 | $3.24M 10-K · filed 2018-04-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |